Cryo-Cell International, Inc.CCELNYSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank93
3Y CAGR+10.6%
5Y CAGR+11.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+10.6%/yr
vs +2.4%/yr prior
5Y CAGR
+11.4%/yr
Consistent
Acceleration
+8.2pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $23.71M | +15.3% |
| 2024 | $20.56M | -41.7% |
| 2023 | $35.26M | +101.2% |
| 2022 | $17.52M | +10.3% |
| 2021 | $15.88M | +14.8% |
| 2020 | $13.83M | -8.6% |
| 2019 | $15.13M | -4.9% |
| 2018 | $15.90M | +16.5% |
| 2017 | $13.65M | -8.6% |
| 2016 | $14.93M | - |